These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9576120

  • 1. Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction.
    Bagrov AY, Fedorova OV, Dmitrieva RI, Howald WN, Hunter AP, Kuznetsova EA, Shpen VM.
    Hypertension; 1998 May; 31(5):1097-103. PubMed ID: 9576120
    [Abstract] [Full Text] [Related]

  • 2. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
    Bagrov AY, Dmitrieva RI, Fedorova OV, Kazakov GP, Roukoyatkina NI, Shpen VM.
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):982-90. PubMed ID: 8896650
    [Abstract] [Full Text] [Related]

  • 3. Endogenous marinobufagenin-like factor in acute plasma volume expansion.
    Fedorova OV, Doris PA, Bagrov AY.
    Clin Exp Hypertens; 1998 Oct; 20(5-6):581-91. PubMed ID: 9682914
    [Abstract] [Full Text] [Related]

  • 4. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
    Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY.
    J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
    [Abstract] [Full Text] [Related]

  • 5. Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs.
    Bagrov AY, Fedorova OV, Dmitrieva RI, French AW, Anderson DE.
    Cardiovasc Res; 1996 Feb; 31(2):296-305. PubMed ID: 8730407
    [Abstract] [Full Text] [Related]

  • 6. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV, Kolodkin NI, Agalakova NI, Lakatta EG, Bagrov AY.
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV, Bagrov AY.
    Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
    [Abstract] [Full Text] [Related]

  • 8. Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta.
    Bagrov AY, Roukoyatkina NI, Pinaev AG, Dmitrieva RI, Fedorova OV.
    Eur J Pharmacol; 1995 Feb 14; 274(1-3):151-8. PubMed ID: 7768267
    [Abstract] [Full Text] [Related]

  • 9. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
    Fedorova OV, Agalakova NI, Morrell CH, Lakatta EG, Bagrov AY.
    Hypertension; 2006 Dec 14; 48(6):1160-8. PubMed ID: 17043158
    [Abstract] [Full Text] [Related]

  • 10. Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats.
    Fedorova OV, Anderson DE, Bagrov AY.
    Am J Hypertens; 1998 Jul 14; 11(7):796-802. PubMed ID: 9683040
    [Abstract] [Full Text] [Related]

  • 11. [Bufodienolide nature of endogenous inhibitor of human sodium-potassium adenosine triphosphatase].
    Dmitrieva RI, Georgiev IIu, Shpen' VM, Bagrov AIa.
    Zh Evol Biokhim Fiziol; 1997 Jul 14; 33(3):355-63. PubMed ID: 9479394
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis of an Endogenous Steroidal Na Pump Inhibitor Marinobufagenin, Implicated in Human Cardiovascular Diseases, Is Initiated by CYP27A1 via Bile Acid Pathway.
    Fedorova OV, Zernetkina VI, Shilova VY, Grigorova YN, Juhasz O, Wei W, Marshall CA, Lakatta EG, Bagrov AY.
    Circ Cardiovasc Genet; 2015 Oct 14; 8(5):736-45. PubMed ID: 26374826
    [Abstract] [Full Text] [Related]

  • 13. Endogenous marinobufagenin-like immunoreactive factor and Na+, K+ ATPase inhibition during voluntary hypoventilation.
    Bagrov AY, Fedorova OV, Austin-Lane JL, Dmitrieva RI, Anderson DE.
    Hypertension; 1995 Nov 14; 26(5):781-8. PubMed ID: 7591018
    [Abstract] [Full Text] [Related]

  • 14. Marinobufagenin, an endogenous inhibitor of alpha-1 Na/K-ATPase, is a novel factor in pathogenesis of diabetes mellitus.
    Bagrov YY, Manusova NB, Egorova IA, Frolova EV, Fedorova OV, Bagrov AY.
    Dokl Biol Sci; 2005 Nov 14; 404():333-7. PubMed ID: 16405108
    [No Abstract] [Full Text] [Related]

  • 15. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M, Harris TM, Konishi F, Inagami T.
    Eur J Biochem; 1993 Jan 15; 211(1-2):317-27. PubMed ID: 8381085
    [Abstract] [Full Text] [Related]

  • 16. Identification of a ouabain-like compound in toad skin and plasma as a bufodienolide derivative.
    Lichtstein D, Kachalsky S, Deutsch J.
    Life Sci; 1986 Apr 07; 38(14):1261-70. PubMed ID: 3007907
    [Abstract] [Full Text] [Related]

  • 17. [Effects of marinobufagenin on electrophysiological and contractile characteristics of the rat diaphragm].
    Krivoĭ II, Kravtsova VV, Prokof'ev AV, Vashchinkina EV, Kubasov IV, Drabkina TM.
    Ross Fiziol Zh Im I M Sechenova; 2006 Dec 07; 92(12):1463-73. PubMed ID: 17523467
    [Abstract] [Full Text] [Related]

  • 18. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
    Kramer HJ, Krampitz G, Bäcker A, Michel H, Krampitz G, Meyer-Lehnert H.
    Am J Hypertens; 1995 Jul 07; 8(7):753-60. PubMed ID: 7546503
    [Abstract] [Full Text] [Related]

  • 19. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
    Fedorova OV, Zhuravin IA, Agalakova NI, Yamova LA, Talan MI, Lakatta EG, Bagrov AY.
    J Hypertens; 2007 Sep 07; 25(9):1834-44. PubMed ID: 17762648
    [Abstract] [Full Text] [Related]

  • 20. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
    Fedorova OV, Talan MI, Agalakova NI, Droy-Lefaix MT, Lakatta EG, Bagrov AY.
    Hypertension; 2003 Mar 07; 41(3):505-11. PubMed ID: 12623951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.